학술논문
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
Document Type
Article
Author
Cunningham, S.; Piedra, P.A.; Martinon-Torres, F.; Szymanski, H.; Brackeva, B.; Dombrecht, E.; Detalle, L.; Fleurinck, C.; Piedra, P.A.; Verhulst, S.; Matthijs, I.; Proesmans, M.; Goetghebuer, T.; Bosheva, M.; Dosev, S.; Nikolova, O.; Chakarova, P.; Wu Hupat, E.; Mesa Monsalve, J.; Turkalj, M.; Mesaric Antoncic, N.; Tesovic, G.; SIPL, M.; Kljaic Bukvic, B.; Ivkovic-Jurekovic, I.; Cicak, B.; Skalova, S.; Horneff, G.; Vogelberg, C.; Gacs, É.; Kalocsai, K.; Madarasi, A.; Kovacs, L.; Novak, Z.; Bene, Z.; Ashkenazi, S.; Goldbart, A.; Bentur, L.; Kolosa, N.; Gardovska, D.; Khaw, P.G.; Toh, T.H.; De Bruyne, J.A.; Tan, K.K.; Alberto, E.; Sablan, B.J.; de Leon, A.; Repko, M.; Kralinsky, K.; Salamanca de la Cueva, I.; Rodrigo Gonzalo de Liria, C.; Cedena Romero, M.P.; Monteagudo Montesinos, E.; Teeratakulpisarn, J.; Puthanakit, T.; Oberdorfer, P.; Warachit, B.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, January 2021, 9(1):21-32)
Subject
Language
English
ISSN
22132619
22132600
22132600